Covid-19: US approves remdesivir despite WHO trial showing lack of efficacy

The US Food and Drug Administration has approved remdesivir for adults and children (12 years and over, weighing at least 40 kg) who need to be admitted to hospital for covid-19 treatment. This is the first drug for covid-19 that the FDA has approved. The approval came despite the World Health Organization’s Solidarity trial reporting that the drug had little to no effect on 28 day mortality and…

Read the full article here

Related Articles